MHRA Fees Review and Uplift Consultancy

The Medicines and Healthcare Products Regulatory Agency (MHRA) is seeking consultancy support to deliver a comprehensive fees review and uplift project comprising four key workstreams: (1) Benchmarking, value proposition and performance guarantees analysis; (2) SME and voucher scheme design; (3) External challenge and quality assurance of the MHRA internal financial model; and (4) Price elasticity and market response assessment. This project will review and revalue MHRA fees to ensure they cover the costs of capacity strengthening initiatives that will deliver improved regulatory services to the pharmaceutical and medical device industry. The outcomes will directly support the draft MHRA 2030 strategy. Suppliers should have expertise in regulatory fee structures, financial benchmarking, market analysis, and scheme design to support MHRA's modernisation agenda.